PHARMACEUTICAL FORMULATION

摘要

PURPOSE: A pharmaceutical formulation containing immediate release atorvastatin and sustained release olmesartan is provided to treat coronary artery disease and maximize body absorption of drug. CONSTITUTION: A pharmaceutical formulation contains immediate release compartment of atorvastatin and sustained release compartment of olmesartan. The olmesartan is its isomer, its pharmaceutically acceptable salt, or its prodrug. An olmesartan prodrug is olmesartan medoxomil.